Showing results (131-140 of 237) with videos related to

Sort By:
Pageof 24
Journal of the National Cancer Institute|October 18, 1989
Effect of sodium thiosulfate on the pharmacokinetics and toxicity of cisplatinR Goel, S M Cleary, C Horton, et al.
Frontiers in Immunology|May 29, 2019
Nanoemulsion Adjuvant Augments Retinaldehyde Dehydrogenase Activity in Dendritic Cells via MyD88 PathwayMohammad Farazuddin, Rishi R Goel, Nicholas J Kline, et al.
Toxicology and Applied Pharmacology|October 1, 1996
Cytotoxicity, accumulation, and efflux of cisplatin and its metabolites in human ovarian carcinoma cellsF H Shirazi, J M Molepo, D J Stewart, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|July 25, 2000
Effects of crocetin on pulmonary gas exchange in foxhounds during hypoxic exerciseP D Wagner, C C Hsia, R Goel, et al.
Current Oncology (Toronto, Ont.)|April 21, 2010
Diagnosis and management of hepatocellular carcinoma: results of a consensus meeting of The Ottawa Hospital Cancer CentreT Asmis, F Balaa, L Scully, et al.
Hernia : the Journal of Hernias and Abdominal Wall Surgery|August 29, 2022
Practice and short-term outcomes in ventral hernia repair: a prospective multicenter data audit of Indian Association of Gastrointestinal Endo Surgeons Research CollaborativeS J Baig, M Y Afaque, P Priya, et al.
Gynecologic Oncology|June 1, 1993
High-dose biweekly intraperitoneal cisplatin: an effective way to increase cisplatin dose intensityA Bonetti, S B Howell, E McClay, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1993
Dose intensification of cisplatin chemotherapy through biweekly administrationS Kim, S B Howell, E McClay, et al.
European Journal of Biochemistry|May 15, 1993
Catalytic antibody activity elicited by active immunisation. Evidence for natural variation involving preferential stabilization of the transition stateG Gallacher, C S Jackson, M Searcey, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Association of cisplatin nephrotoxicity with patient characteristics and cisplatin administration methodsD J Stewart, C S Dulberg, N Z Mikhael, et al.
Pageof 24